David A. Vort Sells 4,286 Shares of Irhythm Technologies Inc (IRTC) Stock

Irhythm Technologies Inc (NASDAQ:IRTC) EVP David A. Vort sold 4,286 shares of the stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $92.66, for a total transaction of $397,140.76. Following the completion of the sale, the executive vice president now directly owns 23,088 shares in the company, valued at $2,139,334.08. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

David A. Vort also recently made the following trade(s):

  • On Friday, December 7th, David A. Vort sold 5,176 shares of Irhythm Technologies stock. The stock was sold at an average price of $73.31, for a total transaction of $379,452.56.

Shares of IRTC stock traded down $0.40 during trading hours on Thursday, hitting $93.23. 204,000 shares of the company were exchanged, compared to its average volume of 341,954. The firm has a market cap of $2.22 billion, a P/E ratio of -49.33 and a beta of 1.77. Irhythm Technologies Inc has a 1 year low of $55.18 and a 1 year high of $98.37. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.79 and a quick ratio of 4.69.

Irhythm Technologies (NASDAQ:IRTC) last announced its quarterly earnings data on Tuesday, February 12th. The company reported ($0.48) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.45) by ($0.03). Irhythm Technologies had a negative return on equity of 66.24% and a negative net margin of 32.78%. The company had revenue of $43.16 million for the quarter, compared to analysts’ expectations of $40.21 million. During the same quarter in the previous year, the company earned ($0.48) earnings per share. The company’s revenue was up 53.2% on a year-over-year basis. Analysts expect that Irhythm Technologies Inc will post -1.69 earnings per share for the current fiscal year.

Several equities research analysts have issued reports on IRTC shares. Royal Bank of Canada raised their price target on shares of Irhythm Technologies to $109.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 13th. Northland Securities reaffirmed a “hold” rating and set a $75.00 price target on shares of Irhythm Technologies in a research note on Wednesday, February 13th. BidaskClub raised shares of Irhythm Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, January 30th. BTIG Research reaffirmed a “hold” rating on shares of Irhythm Technologies in a research note on Wednesday, February 13th. Finally, BMO Capital Markets raised their price target on shares of Irhythm Technologies from $96.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 13th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $98.25.

Several institutional investors and hedge funds have recently bought and sold shares of the company. PNC Financial Services Group Inc. raised its stake in shares of Irhythm Technologies by 38.9% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,278 shares of the company’s stock valued at $89,000 after purchasing an additional 358 shares during the period. CIBC Private Wealth Group LLC raised its stake in shares of Irhythm Technologies by 13.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 3,275 shares of the company’s stock valued at $228,000 after purchasing an additional 400 shares during the period. United Services Automobile Association raised its stake in shares of Irhythm Technologies by 15.3% during the fourth quarter. United Services Automobile Association now owns 3,444 shares of the company’s stock valued at $239,000 after purchasing an additional 458 shares during the period. Nuveen Asset Management LLC raised its stake in shares of Irhythm Technologies by 3.6% during the fourth quarter. Nuveen Asset Management LLC now owns 15,180 shares of the company’s stock valued at $1,055,000 after purchasing an additional 531 shares during the period. Finally, Legal & General Group Plc raised its stake in shares of Irhythm Technologies by 6.0% during the fourth quarter. Legal & General Group Plc now owns 9,588 shares of the company’s stock valued at $666,000 after purchasing an additional 541 shares during the period. Institutional investors own 98.98% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “David A. Vort Sells 4,286 Shares of Irhythm Technologies Inc (IRTC) Stock” was originally posted by WKRB News and is the sole property of of WKRB News. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.wkrb13.com/2019/02/22/david-a-vort-sells-4286-shares-of-irhythm-technologies-inc-irtc-stock.html.

About Irhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.

Further Reading: Ex-Dividend

Insider Buying and Selling by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for Irhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.